Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E MAY

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|March 12, 1993
int-2 amplification in breast cancer: association with decreased survival and relationship to amplification of c-erbB-2 and c-mycJ A Henry, C Hennessy, D L Levett, et al.
The Journal of Biological Chemistry|August 25, 1984
Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublinesB Westley, F E May, A M Brown, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cellsL R Wiseman, M D Johnson, A E Wakeling, et al.
Nucleic Acids Research|June 11, 1981
Quantitation of DNase I sensitivity in Xenopus chromatin containing active and inactive globin, albumin and vitellogenin genesB K Felber, S Gerber-Huber, C Meier, et al.
Journal of the American Geriatrics Society|September 1, 1989
Incidence of hypertension in an ambulatory elderly populationR A Davidson, W E Hale, M T Moore, et al.
British Journal of Cancer|October 1, 1991
Expression of the pNR-2/pS2 protein in diverse human epithelial tumoursJ A Henry, M K Bennett, N H Piggott, et al.
British Journal of Cancer|April 1, 1991
pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine responseJ A Henry, N H Piggott, U K Mallick, et al.
Cell|May 1, 1983
In contrast to other Xenopus genes the estrogen-inducible vitellogenin genes are expressed when totally methylatedS Gerber-Huber, F E May, B R Westley, et al.
Journal of Hepatology|March 1, 1992
c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinomaJ D Collier, K Guo, J Mathew, et al.
Health Education Research|August 18, 2004
Do benefits and barriers differ by stage of adoption for colorectal cancer screening?S M Rawl, U Menon, V L Champion, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|March 12, 1993
int-2 amplification in breast cancer: association with decreased survival and relationship to amplification of c-erbB-2 and c-mycJ A Henry, C Hennessy, D L Levett, et al.
The Journal of Biological Chemistry|August 25, 1984
Effects of antiestrogens on the estrogen-regulated pS2 RNA and the 52- and 160-kilodalton proteins in MCF7 cells and two tamoxifen-resistant sublinesB Westley, F E May, A M Brown, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cellsL R Wiseman, M D Johnson, A E Wakeling, et al.
Nucleic Acids Research|June 11, 1981
Quantitation of DNase I sensitivity in Xenopus chromatin containing active and inactive globin, albumin and vitellogenin genesB K Felber, S Gerber-Huber, C Meier, et al.
Journal of the American Geriatrics Society|September 1, 1989
Incidence of hypertension in an ambulatory elderly populationR A Davidson, W E Hale, M T Moore, et al.
British Journal of Cancer|October 1, 1991
Expression of the pNR-2/pS2 protein in diverse human epithelial tumoursJ A Henry, M K Bennett, N H Piggott, et al.
British Journal of Cancer|April 1, 1991
pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine responseJ A Henry, N H Piggott, U K Mallick, et al.
Cell|May 1, 1983
In contrast to other Xenopus genes the estrogen-inducible vitellogenin genes are expressed when totally methylatedS Gerber-Huber, F E May, B R Westley, et al.
Journal of Hepatology|March 1, 1992
c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinomaJ D Collier, K Guo, J Mathew, et al.
Health Education Research|August 18, 2004
Do benefits and barriers differ by stage of adoption for colorectal cancer screening?S M Rawl, U Menon, V L Champion, et al.
Pageof 10